The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.
Daily News Roundup
The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.
An examination of Swedish health and educational records suggests that more schooling results in healthier adults.
The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.
The University of Michigan is funding exploratory ideas that cross disciplinary boundaries with $20,000 a pop.
A new bill aims to increase transparency in cancer clinical trials by requiring researchers to divulge all outcomes.
The United Kingdom government hatches a plan to provide free public access to government-funded research.
The FDA and NIH dispute reports that clinical trial data is being under-reported.
Principal investigators with medical training have a slightly higher NIH funding rate than those with just a PhD.
California mulls a state law that would criminalize the unauthorized sharing, storing, or analyzing of genetic data.
The White House announces a strategy to foster development of biological products in fields ranging from medicine to agriculture.